Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
GLP-1R agonism not only helps with weight management but also appears to provide neuroprotective effects, including reducing neuroinflammation and enhancing brain health
Targeting the GIPR for obesity: to agonize or antagonize
Its also important to address mental health considerations, as neurodivergent individuals have higher rates of anxiety and depression
Retatrutide Structure and Chemistry Retatrutide builds on the engineering principles refined in semaglutide and tirzepatide: Glucagon-based peptide backbone retatrutide is derived from glucagon, with modifications to give it activity at all three target receptors Strategic amino acid substitutions multiple substitutions tune the receptor activity balance across GLP-1R, GIPR, and glucagon receptor Fatty acid chain attached for albumin binding and extended half-life (similar strategy to semaglutide and tirzepatide) Aminoisobutyric acid substitutions protect against DPP-4 enzymatic degradation The triple-agonist design is technically demanding because each receptor has different binding requirements
